GLP-1 drugs help people lose weight, which is important because the risks from obesity account for 40% of all cancer diagnoses in the U.S., impacting prognosis and survival
Weight loss has long been a cornerstone of preventive health yet for many people, traditional strategies like diet and exercise alone don't deliver lasting results
Plant Cell 13 , 27932807 (2001)
GLP-1 RAs were significantly associated with gastrointestinal AEs, and the association was further attributed to liraglutide, dulaglutide, and semaglutide
Semaglutide has the strongest cardiovascular outcome data of any GLP-1 medication, with the SELECT trial demonstrating a 20% reduction in major adverse cardiovascular events in adults with obesity and established cardiovascular disease but without diabetes
Contact, appointment request, event RSVP, and service inquiry form for Refresh Beauty & Wellness